Pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
A use of (S)-(-)--ethyl-2-oxo-1-pyrrolidineacetamide for the manufacture
of a medicament for treatment of particular disease and new pharmaceutical compositions
comprising (S)-(-)--ethyl-2-oxo-1-pyrrolidineacetamide.